During the past decade, Spitali Amerikan conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spitali Amerikan" are "COVID-19" (1 trials), "Menstrual Pain" (1 trials), "Recurrent Implantation Failure" (1 trials) and "Uterine Adenomyosis" (1 trials). Many other conditions were trialed in "Spitali Amerikan" in a lesser frequency.

Most popular intervention types in "Spitali Amerikan" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase inhibitor plus GnRH analog (3,75mg Leuprolide)" (1 trials), "GnRH analog (3,75mg Leuprolide)" (1 trials) and "Standard of health care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitali Amerikan" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Spitali Amerikan". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Spitali Amerikan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spitali Amerikan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".